iRay Group (SHA:688301)
China
· Delayed Price · Currency is CNY 133.40
+4.70 (3.65%)
Jun 5, 2025, 3:00 PM CST
iRay Group Market Cap
iRay Group has a market cap or net worth of 19.06 billion as of June 5, 2025. Its market cap has decreased by -11.68% in one year.
Market Cap
19.06B
Enterprise Value
20.55B
Revenue
1.85B
Ranking
n/a
PE Ratio
37.78
Stock Price
133.40
Market Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 19.06B, an increase of 64.11%. That is a compound annual growth rate of 11.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 19.06B | 39.58% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | 12.46B | 7.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 363.22B |
| Shenzhen Mindray Bio-Medical Electronics | 276.77B |
| WuXi AppTec | 186.70B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.56B |
| Sichuan Biokin Pharmaceutical | 122.55B |
| Aier Eye Hospital Group | 118.03B |
| Shanghai United Imaging Healthcare | 116.46B |
| Yunnan Baiyao Group Co.,Ltd | 101.51B |